From: Vidya Chande, MD and Esther Park, PharmD, Chairs of Pharmacy & Therapeutics (P&T) Committee, Seattle Children’s

  • Synagis prophylaxis will end Friday, March 4, 2022 due to an exponential decline in RSV rates and related admissions.
  • We will continue to monitor RSV rates around changing COVID-19 rates and responses
  • Please consult state-specific recommendations for patients outside of our local area.

For More Information: Review WA state and other data from the CDC.